Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2529 studies found for:    anemia
Show Display Options
Rank Status Study
21 Completed Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia
Condition: Fanconi Anemia
Intervention: Drug: Etanercept
22 Recruiting The Benefits of a Preoperative Anemia Management Program
Condition: Anemia, Iron-Deficiency
Interventions: Drug: Iron sucrose;   Drug: Epoetin Alfa;   Other: Blood Transfusion
23 Recruiting Therapeutic Use of the Amino Acid, Leucine in the Treatment of Transfusion - Dependent Diamond Blackfan Anemia Patients
Conditions: Diamond Blackfan Anemia;   Blackfan Diamond Syndrome;   DBA;   Congenital Hypoplastic Anemia;   Pure Red Cell Aplasia
Intervention: Drug: leucine
24 Completed
Has Results
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
Conditions: Anemia, Aplastic;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Kostmann Syndrome
Intervention: Device: Allogeneic stem cell transplant
25 Completed Iron Supplementation Among Low-Income Postpartum Women
Condition: Anemia
Interventions: Behavioral: Daily iron supplements of 65 mg a day for 3 months;   Behavioral: Universal anemia screening and treatment;   Behavioral: Selective anemia screening and treatment
26 Completed Prevention of Severe Anaemia in Gambian Children
Condition: Anemia
Intervention: Drug: sulfadoxine-pyrimethamine
27 Recruiting Quercetin in Children With Fanconi Anemia; a Pilot Study
Condition: Fanconi Anemia
Intervention: Drug: Quercetin (dietary supplement)
28 Completed A Functional Food for the Prevention of Iron-deficiency Anemia
Condition: Anemia
Interventions: Other: Control bread;   Other: Teff Bread
29 Terminated Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants
Condition: Fanconi Anemia
Interventions: Genetic: microarray analysis;   Procedure: biopsy
30 Enrolling by invitation Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
Condition: Anemia
Interventions: Dietary Supplement: Vitamin D3 .;   Drug: omega-3 fatty acids (fish oil);   Dietary Supplement: Vitamin D3 placebo;   Dietary Supplement: Fish oil placebo
31 Completed Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
Conditions: Iron Deficiency Anemia;   Subclinical Hypothyroidism
Interventions: Drug: Ferrous sulfate tablets 325 mg, po, TID;   Drug: Ferrous sulfate plus levothyroxine
32 Completed Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
Conditions: Pregnancy;   Iron Deficiency;   Iron Deficiency Anemia
Interventions: Dietary Supplement: Lattoglobina (Grunenthal) containing bLf;   Drug: FerroGrad by Abbott
33 Recruiting Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia;   Sickle Cell Disease
Intervention:
34 Not yet recruiting Use of Cast Iron Pots to Improve Maternal Anemia
Condition: Iron-deficiency Anemia
Intervention: Device: Cast Iron Pot
35 Active, not recruiting Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Alemtuzumab (Campath-1H);   Drug: Thymoglobulin (r-ATG);   Drug: Cyclosporine (CsA)
36 Completed The Anemia Control Program: Early Intervention
Condition: Iron Deficiency Anemia
Interventions: Behavioral: Home stimulation;   Behavioral: Surveillance;   Dietary Supplement: Iron
37 Completed Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
Conditions: Iron Deficiency;   Anemia;   Kidney Disease
Interventions: Drug: ferumoxytol;   Drug: iron sucrose
38 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
39 Terminated Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer
Condition: Chemotherapy Induced Anemia
Interventions: Biological: Biological: ACE-011;   Drug: Placebo
40 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years